News for LSDI Stock

Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity’ for Growth, Success Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction  Lucy Scientific Discovery Inc. Taps Fortune 500 Veteran and Current Executive Chairman Richard Nanula as New CEO Lucy Scientific Discovery Inc. Unveils New Sleep Aid Product: Twilight by Lucy Lucy Scientific Discovery Reiterates Its Proposal to Acquire Pasithea Therapeutics Corp. Lucy Scientific Discovery to Present at the LD Micro Invitational XIII Conference on June 7 Lucy Scientific Discovery Announces Proposal to Acquire Pasithea Therapeutics Corp. Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels Lucy Scientific Discovery Inc. Announces Sponsorship at the Psychedelic Science Conference June 19-25, 2023 Lucy Scientific Discovery Announces Share Repurchase Program Lucy Scientific Discovery Announces Partnership with High Times® to Develop and Distribute a New Line of Psychoactive Products Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs WestPark Capital Announces Closing of $7.5 Million IPO for Lucy Scientific Discovery Inc. (NASDAQ:LSDI) Lucy Scientific Discovery Files Amendment with Health Canada to Expand its List of Controlled Substances to Include Cocaine and Heroin; This Expansion Represents an Effort to Supply Harm Reduction Programs Around the World Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering Lucy Scientific Discovery Inc. NASDAQ:LSDI Announces Pricing of $7.5 Million IPO